IMYCN/I Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells
International journal of molecular sciences, 2023-03, Vol.24 (6) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 1422-0067 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms24065408
Full text available